3 results about "Merocyanine dye" patented technology

The invention relates to liquid sanitizing and / or disinfecting compositions comprising an active agent, an indicator compound, an acid, and a solvent. The compositions may be applied to a surface by spraying or transferring from cleaning article, in order to eliminate pathogens on the surface. The indicator compound may comprise a dye such as a cyanine dye, which provides a color to the composition and has at least one absorption maxima in the visible region. Once applied to the surface, the composition undergoes a color transition and becomes colorless.

A negative working lithographic printing plate precursor has a negative working infrared radiation sensitive image recording layer having a) two or more free radical polymerizable components; b) an initiator composition capable of generating free radicals; and c) one or more infrared radiation absorbing cyanine dyes. A) the two or more radically polymerizable components comprise a combination of a urethane (meth) acrylate and a polyester (meth) acrylate together making up 75-100% by weight of all the radically polymerizable components. The weight ratio of the urethane (meth) acrylate to the polyester (meth) acrylate is from 90: 10 to 35: 65. The urethane (meth) acrylate comprises one or more urethane linkages and at least 4 acrylate groups or methacrylate groups. The one or more polyester (meth) acrylates each do not contain a urethane bond and are represented by the following structure (I). These precursors are less sensitive to ambient ozone and can be imaged by infrared radiation and developed on-press during lithographic printing.

This invention relates to the field of optical imaging. More specifically, it relates to fluorescent probes capable of effectively targeting prostate-specific membrane antigen (PSMA) and comprising heptamethrin dye having near-infrared (NIR) emission. The invention also relates to methods for preparing these compounds, pharmaceutical compositions and kits for introducing these compounds, and methods for using them as optical diagnostic agents in the imaging or treatment of diseases, particularly prostate cancer.